26 November 2024 : Clinical Research
Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis
Mustafa Karaca1ACDEF, Mustafa Serkan Alemdar2BDF, Özge Deniz Karaca3ABEF, Yıldız Kılar4BD, Gökhan Köker3BEF, Hasan Sözel5CDE, Mustafa Yıldız2DEF, Gülhan Özçelik Köker1DEF, Mustafa Özgür Arici
2BDEF*
DOI: 10.12659/MSM.945240
Med Sci Monit 2024; 30:e945240
Table 2 Treatment response, recurrence/progression and final status of the patients.
| Variables | n | % | |
|---|---|---|---|
| Non-pCR | 133 | 58.8 | |
| pCR | 93 | 41.2 | |
| 1 | 21 | 9.3 | |
| 2 | 43 | 19 | |
| 3 | 48 | 21.2 | |
| 4 | 21 | 9.3 | |
| 5 | 93 | 41.2 | |
| No response | 21 | 9.3 | |
| Partial response | 112 | 49.6 | |
| Complete response | 93 | 41.2 | |
| Progressive disease | 1 | 0.4 | |
| Stable disease | 13 | 5.8 | |
| Partial response | 153 | 67.7 | |
| Complete response | 53 | 23.5 | |
| Absent | 206 | 91.2 | |
| Present | 20 | 8.8 | |
| Deceased | 8 | 3.5 | |
| Alive | 218 | 96.5 | |
| NAC – neoadjuvant chemotherapy; pCR – pathologic complete response. | |||